The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 01, 2020

Filed:

Jun. 12, 2018
Applicant:

University of Utah Research Foundation, Salt Lake City, UT (US);

Inventors:

Hamid Ghandehari, Salt Lake City, UT (US);

Joseph Cappello, Salt Lake City, UT (US);

Azadeh Poursaid, Salt Lake City, UT (US);

Mark Martin Jensen, Salt Lake City, UT (US);

Assignee:

UNIVERSITY OF UTAH RESEARCH FOUNDATION, Salt Lake City, unknown;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/65 (2006.01); A61K 9/06 (2006.01); A61K 47/42 (2017.01); A61K 31/44 (2006.01); A61K 9/14 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/65 (2013.01); A61K 9/0024 (2013.01); A61K 9/06 (2013.01); A61K 9/146 (2013.01); A61K 31/44 (2013.01); A61K 47/42 (2013.01);
Abstract

Described herein are chemoembolic compositions and agents. The compositions include one or more anti-cancer agents and a silk-elastinlike protein polymer, wherein the compositions are liquids prior to administration to a subject but convert to hydrogels upon administration to the subject. Administration of the chemoembolic compositions to tumor and/or tumor vasculature in a subject having cancer can result in reduced or inhibited blood flow to the tumor as well as localized, sustained release of the anti-cancer agent in the vicinity of the tumor. Reduction in blood flow, in turn, results in a reduction of tumor volume and/or inhibition of tumor growth, while localized release of the anti-cancer agent results in reduced systemic effects and lower overall toxicity of treatment with the compositions.


Find Patent Forward Citations

Loading…